The Global DNA Vaccine Market size is expected to display higher growth rate over the next seven years. The market is subject to witness a substantial growth due to the high-end demand for effective and low cost vaccines. Growing prevalence of infectious diseases, ever-increasing geriatric population, rising vulnerability towards genetic diseases and rising number of resistant pathogens are expected to drive market demand for DNA vaccines in the upcoming years.
Additionally, higher approval rate by local & international organization in veterinary sector owing to the proven long lasting results of DNA vaccines and higher performance in comparison with the traditional vaccines are likely positively affect market growth. Globally, the market is predicted to generate massive revenue over the next seven years, providing numerous opportunities for market players to invest for research and development in the DNA vaccine market.
Factors responsible for the growth of the industry are rise in adoption of personalized medicine applications and DNA identification as a therapy. The personalised medicine application helps in the treatment of number of chronic diseases, thus driving the need for HLA typing for therapies. Furthermore, recent technological advancement and increasing adoption of digital services in healthcare sector is leads in increase of commercialization for next generation diagnostics, which is expected to fuel market demand for DNA vaccine over the forecast period. Rising influence of commercialization and digitalization in healthcare sector are driving the demand for DNA vaccine, in the recent years.
DNA vaccine helps to protect against disease with the help of genetically engineered DNA that are capable of producing various antigens and protective immunological response in the human and animal’s body. DNA vaccines offers numerous advantages over the conventional vaccines due to their wider range of immune response types. These factors are expected to pave the way for future market growth of DNA vaccines. Increasing demand for DNA vaccines for veterinary use is projected to foster market growth over the forecast period.
Current DNA vaccines are referred as third generation vaccines as they consist of DNA that codes for specific proteins or antigens from a given pathogen. These DNA are injected into the animal or human body, which is then taken up by cells. Such cells undergo normal metabolic processes and synthesize proteins based on the genetic code in the plasmid. This process triggers immune responses in the patient. These factors are propelling the demand for DNA vaccines to boost immune response of the animal or human body.
The market is broadly categorized into two major segments based on the application type such as human DNA vaccines and animal DNA vaccines. The animal DNA vaccines is considered as one of the fastest growing segment in the DNA vaccine market with substantial revenue generation in the last few years.
Growing popularity of the animal DNA vaccines segment is attributed to the higher approval rate and current development in the field of DNA synthesis, immunology and molecular biology. The human DNA vaccines segment has also witnessed substantial growth due to increase in investment by private and government authorities in research & development activities across the globe.
The market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine & pharmaceutical industry, prevalence of genetic diseases, increase in the number of research & development activities and existence of well-established healthcare infrastructure in the region.
Asia-Pacific region is predicted to hold major market share in the DNA vaccine market with massive growth in forecast period. Countries such as India, China and Singapore are leading the Asia-Pacific market with strong economic growth in the region, ever-growing geriatric population, increasing healthcare expenditure, and significant investment by leading industry players considering potential growth opportunities in the region.
The key players in the DNA vaccine market are Arbutus Biopharma Co., Sanofi S.A., Vical Ltd., Astellas Pharma, Inc., Dendreon Co., Merck & Co., Invio Biomedical, Inc., and Novartis Animal Health, Inc.
Research Support Specialist, USA